| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Microbiology and Immunology,
2 Lineberger Comprehensive Cancer Center
and3 Division of Infectious Disease, The University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599-7295, U.S.A.
The sequence of the latent membrane protein 1 (LMP-1) gene was analysed in Epstein—Barr virus (EBV) isolates from specific regions representing both type 1 and type 2 EBV. A predominant strain marked by an XhoI restriction enzyme polymorphism (REP) within the LMP-1 gene has been identified in type 1 EBV in nasopharyngeal carcinoma (NPC) from Southern China. This polymorphism was also present in type 2 EBV in NPC from Alaska. In this study, the sequence of the LMP-1 gene was determined in these samples representing type 1 and type 2 EBV and was compared with the prototype lymphoid strains. Consistent nucleotide variation in the amino terminus of LMP-1 was identified in strains marked by the XhoI REP. These changes were present in both EBV type 1 and type 2 strains. Three types of sequence variation were detected in the carboxy terminus of LMP-1. The LMP-1 sequences differed in the number of an 11 amino acid repeat element. In the prototype EBV type 1 (B95-8) sequence and in the type 1 Raji and type 2 HR-1 strains, the third repeat element contained an insertion of 5 amino acids that were also the first five unique amino acids after the last partial repeat element. The third variation was a deletion of amino acids 343 to 352 of the B95-8 LMP-1. This deletion was detected in the type 1 Chinese EBV strains, but was not detected in the type 2 Alaskan strains although the Chinese and Alaskan strains have nearly identical amino acid changes at the amino terminus. Numerous other amino acid changes were detected in the carboxy terminus which did not cosegregate with either EBV type, amino acid changes in the amino terminus, or specific geographic regions. These data indicate that EBV strains can be distinguished by sequence differences within LMP-1 and that unlike the divergence between type 1 and type 2 EBV in Epstein—Barr nuclear antigen sequences, different EBV types are nearly identical in LMP-1 sequence.
Received 3 February 1994;
accepted 27 April 1994.
This article has been cited by other articles:
|
|
 |
|
  N. Faumont, A. Chanut, A. Benard, N. Cogne, G. Delsol, J. Feuillard, and F. Meggetto Comparative analysis of oncogenic properties and nuclear factor-{kappa}B activity of latent membrane protein 1 natural variants from Hodgkin's lymphoma's Reed-Sternberg cells and normal B-lymphocytes Haematologica, March 1, 2009; 94(3): 355 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-P. N Chow, C C Wu, H Y Chang, C Chang, and Y S Chang A simplified tumour model established via Epstein-Barr virus-encoded, nasopharyngeal carcinoma-derived oncogene latent membrane protein 1 in immunocompetent mice Lab Anim, April 1, 2008; 42(2): 193 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bhaduri-McIntosh, M. J. Rotenberg, B. Gardner, M. Robert, and G. Miller Repertoire and frequency of immune cells reactive to Epstein-Barr virus-derived autologous lymphoblastoid cell lines Blood, February 1, 2008; 111(3): 1334 - 1343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. T. Chang and H.-O. Adami The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1765 - 1777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Mainou and N. Raab-Traub LMP1 Strain Variants: Biological and Molecular Properties. J. Virol., July 1, 2006; 80(13): 6458 - 6468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Pandya and D. M. Walling Epstein-Barr Virus Latent Membrane Protein 1 (LMP-1) Half-Life in Epithelial Cells Is Down-Regulated by Lytic LMP-1 J. Virol., August 1, 2004; 78(15): 8404 - 8410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Lin, J.-M. Cherng, H.-J. Lin, C.-W. Tsang, Y.-X. Liu, and S. P. Lee Amino acid changes in functional domains of latent membrane protein 1 of Epstein-Barr virus in nasopharyngeal carcinoma of southern China and Taiwan: prevalence of an HLA A2-restricted 'epitope-loss variant' J. Gen. Virol., July 1, 2004; 85(7): 2023 - 2034. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. De Francesco, F. Gargiulo, P. Esteban, P. G. Calzavara-Pinton, M. Venturini, F. Perandin, M. Baronio, C. Pollara, L. Terlenghi, and N. Manca Polymorphism analysis of Epstein-Barr virus isolates of lymphoblastoid cell lines from patients with mycosis fungoides J. Med. Microbiol., May 1, 2004; 53(5): 381 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Edwards, D. Sitki-Green, D. T. Moore, and N. Raab-Traub Potential Selection of LMP1 Variants in Nasopharyngeal Carcinoma J. Virol., January 15, 2004; 78(2): 868 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Tang, O. A. Pavlish, V. S. Spiegelman, A. A. Parkhitko, and S. Y. Fuchs Interaction of Epstein-Barr Virus Latent Membrane Protein 1 with SCFHOS/{beta}-TrCP E3 Ubiquitin Ligase Regulates Extent of NF-{kappa}B Activation J. Biol. Chem., December 5, 2003; 278(49): 48942 - 48949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Midgley, A. I. Bell, D. J. McGeoch, and A. B. Rickinson Latent Gene Sequencing Reveals Familial Relationships among Chinese Epstein-Barr Virus Strains and Evidence for Positive Selection of A11 Epitope Changes J. Virol., November 1, 2003; 77(21): 11517 - 11530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Duraiswamy, J. M. Burrows, M. Bharadwaj, S. R. Burrows, L. Cooper, N. Pimtanothai, and R. Khanna Ex Vivo Analysis of T-Cell Responses to Epstein-Barr Virus-Encoded Oncogene Latent Membrane Protein 1 Reveals Highly Conserved Epitope Sequences in Virus Isolates from Diverse Geographic Regions J. Virol., July 1, 2003; 77(13): 7401 - 7410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Walling, A. L. Brown, W. Etienne, W. A. Keitel, and P. D. Ling Multiple Epstein-Barr Virus Infections in Healthy Individuals J. Virol., June 1, 2003; 77(11): 6546 - 6550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Erickson, C. Berger, W. F. Coffin III, E. Schiff, D. M. Walling, and J. M. Martin Unexpected Absence of the Epstein-Barr Virus (EBV) lyLMP-1 Open Reading Frame in Tumor Virus Isolates: Lack of Correlation between Met129 Status and EBV Strain Identity J. Virol., April 1, 2003; 77(7): 4415 - 4422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sitki-Green, M. Covington, and N. Raab-Traub Compartmentalization and Transmission of Multiple Epstein-Barr Virus Strains in Asymptomatic Carriers J. Virol., February 1, 2003; 77(3): 1840 - 1847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Bryant and P. J. Farrell Signal Transduction and Transcription Factor Modification during Reactivation of Epstein-Barr Virus from Latency J. Virol., September 11, 2002; 76(20): 10290 - 10298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sitki-Green, R. H. Edwards, J. Webster-Cyriaque, and N. Raab-Traub Identification of Epstein-Barr Virus Strain Variants in Hairy Leukoplakia and Peripheral Blood by Use of a Heteroduplex Tracking Assay J. Virol., August 28, 2002; 76(19): 9645 - 9656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Palefsky, J. Berline, D. Greenspan, and J. S. Greenspan Evidence for trafficking of Epstein-Barr virus strains between hairy leukoplakia and peripheral blood lymphocytes J. Gen. Virol., February 1, 2002; 83(2): 317 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-G. Zhou, K. Sandvej, P.-J. Li, X.-L. Ji, Q.-H. Yan, X.-P. Zhang, J.-P. Da, and S. J. Hamilton-Dutoit Epstein-Barr virus gene polymorphisms in Chinese Hodgkin's disease cases and healthy donors: identification of three distinct virus variants J. Gen. Virol., May 1, 2001; 82(5): 1157 - 1167. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Higuchi, K. M. Izumi, and E. Kieff Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: Protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors PNAS, April 10, 2001; 98(8): 4675 - 4680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Sandvej, B S Andresen, X-G Zhou, N Gregersen, and S Hamilton-Dutoit Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site Mol. Pathol., October 1, 2000; 53(5): 280 - 288. [Abstract] [Full Text]
|
|
|
|
|
|
G. Srivastava, K. Y. Wong, A. K. S. Chiang, K. Y. Lam, and Q. Tao Coinfection of multiple strains of Epstein-Barr virus in immunocompetent normal individuals: reassessment of the viral carrier state Blood, April 1, 2000; 95(7): 2443 - 2445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Midgley, N. W. Blake, Q. Y. Yao, D. Croom-Carter, S. T. Cheung, S. F. Leung, A. T. C. Chan, P. J. Johnson, D. Huang, A. B. Rickinson, et al. Novel Intertypic Recombinants of Epstein-Barr Virus in the Chinese Population J. Virol., February 1, 2000; 74(3): 1544 - 1548. [Abstract] [Full Text]
|
|
|
|
|
|
K. M. Izumi, E. C. McFarland, E. A. Riley, D. Rizzo, Y. Chen, and E. Kieff The Residues between the Two Transformation Effector Sites of Epstein-Barr Virus Latent Membrane Protein 1 Are Not Critical for B-Lymphocyte Growth Transformation J. Virol., December 1, 1999; 73(12): 9908 - 9916. [Abstract] [Full Text]
|
|
|
|
|
|
T. Bloss, A. Kaykas, and B. Sugden Dissociation of patching by latent membrane protein-1 of Epstein-Barr virus from its stimulation of NF-{kappa}B activity J. Gen. Virol., December 1, 1999; 80(12): 3227 - 3232. [Abstract] [Full Text]
|
|
|
|
 |
|
 V. P. Khatri, R. A. Baiocchi, R. Peng, A. R. Oberkircher, J. M. Dolce, P. M. Ward, G. P. Herzig, and M. A. Caligiuri Endogenous CD8+ T Cell Expansion During Regression of Monoclonal EBV-Associated Posttransplant Lymphoproliferative Disorder J. Immunol., July 1, 1999; 163(1): 500 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Habeshaw, Q. Y. Yao, A. I. Bell, D. Morton, and A. B. Rickinson Epstein-Barr Virus Nuclear Antigen 1 Sequences in Endemic and Sporadic Burkitt's Lymphoma Reflect Virus Strains Prevalent in Different Geographic Areas J. Virol., February 1, 1999; 73(2): 965 - 975. [Abstract] [Full Text]
|
|
|
|
|
|
R. J. Johnson, M. Stack, S. A. Hazlewood, M. Jones, C. G. Blackmore, L.-F. Hu, and M. Rowe The 30-Base-Pair Deletion in Chinese Variants of the Epstein-Barr Virus LMP1 Gene Is Not the Major Effector of Functional Differences between Variant LMP1 Genes in Human Lymphocytes J. Virol., May 1, 1998; 72(5): 4038 - 4048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Y. Yao, D. S. G. Croom-Carter, R. J. Tierney, G. Habeshaw, J. T. Wilde, F. G. H. Hill, C. Conlon, and A. B. Rickinson Epidemiology of Infection with Epstein-Barr Virus Types 1 and 2: Lessons from the Study of a T-Cell-Immunocompromised Hemophilic Cohort J. Virol., May 1, 1998; 72(5): 4352 - 4363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kanegane, K. Bhatia, M. Gutierrez, H. Kaneda, T. Wada, A. Yachie, H. Seki, T. Arai, S.-i. Kagimoto, M. Okazaki, et al. A Syndrome of Peripheral Blood T-Cell Infection With Epstein-Barr Virus (EBV) Followed by EBV-Positive T-Cell Lymphoma Blood, March 15, 1998; 91(6): 2085 - 2091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Ometto, C. Menin, S. Masiero, L. Bonaldi, A. Del Mistro, A. M. Cattelan, E. D'Andrea, A. De Rossi, and L. Chieco-Bianchi Molecular Profile of Epstein-Barr Virus in Human Immunodeficiency Virus Type 1-Related Lymphadenopathies and Lymphomas Blood, July 1, 1997; 90(1): 313 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sandvej, J. W. Gratama, M. Munch, X.-G. Zhou, R. L.H. Bolhuis, B. Storstein Andresen, N. Gregersen, and S. Hamilton-Dutoit Sequence Analysis of the Epstein-Barr Virus (EBV) Latent Membrane Protein-1 Gene and Promoter Region: Identification of Four Variants Among Wild-Type EBV Isolates Blood, July 1, 1997; 90(1): 323 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Dolcetti, P. Zancai, V. De Re, A. Gloghini, B. Bigoni, B. Pivetta, S. De Vita, A. Carbone, and M. Boiocchi Epstein-Barr Virus Strains With Latent Membrane Protein-1 Deletions: Prevalence in the Italian Population and High Association With Human Immunodeficiency Virus-Related Hodgkin's Disease Blood, March 1, 1997; 89(5): 1723 - 1731. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
